A Pharmacokinetic Study of Aleglitazar in Healthy Chinese Volunteers
NCT01711775
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
16
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Volunteer
Interventions
DRUG:
aleglitazar
Sponsor
Hoffmann-La Roche